Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Post by malibukion Dec 31, 2016 11:36am

253 Views

Post# 25656705

communication on update

What I asked: "I wonder when roughly would be the next Sirona update regarding receipt of term sheets, decision on how to go further on SBM 1067 etc." Reaponse "I dont have an answer for that. We will always release material items as we receive them and if we are not bound by confidentiality." Either communications are confidential or they have not received anything yet. Anyway I will load more when market opens. Happy new year to all.

Bullboard Posts

10 best-performing AI stocks for Canadian investors